33

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd

336570 · KQ · Healthcare / Medical Devices

3,560.00KRW+30.00 (+0.85%)

Price History

Full chart

Market Stats

Previous Close3,530.00
Open3,575.00
Day Range3,480.00 – 3,680.00
52-Week Range4,130.00 – 10,480.00
Volume451.92K
Market Cap442.04B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.00%
Beta0.93
50-Day Avg4,968.20
200-Day Avg6,781.45

About

WON TECH Co.,Ltd. engages in the production and sale of laser and energy-based equipment in South Korea and internationally. The company offers aesthetics, skincare, homecare, and surgical usage equipment. It also provides products for the treatments, including face lifting and tightening, body contouring, skin rejuvenation, tattoo removal, scars and striae, vascular lesions, hair removal, and surgical. The company was formerly known as WONTECHnology and changed its name to WON TECH Co.,Ltd. in 2013. WON TECH Co.,Ltd. was founded in 1999 and is headquartered in Daejeon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jung-hyun Kim
  • Employees284
  • Headquarters64 Techno 8-ro, Daejeon, South Korea, Korea
  • Websitehttps://wtlaser.com

Leadership

  • Mr. Jung-hyun KimCEO & Inside Director · b. 1982
  • Mr. Jongwon KimCEO & Chairman · b. 1952
  • Mr. Han-gu LeeChief Financial Officer · b. 1981
  • Mr. Young-seok SeoCTO & Inside Director · b. 1966
  • Ms. Jeong-yoon ChoiC. P. O. · b. 1986

Financials

Income Statement

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-051.06B81.51B115.63B115.25B156.84B
Growth (%)---+59.63%+41.86%-0.32%+36.08%
Cost of Revenue--22.13B32.70B41.37B41.11B51.04B
Gross Profit--28.93B48.81B74.26B74.14B105.79B
Gross Margin--56.66%59.89%64.22%64.33%67.45%
Operating Expense--29.02B22.06B28.33B39.46B54.11B
Operating Income-27.14M-47.13M-90.18M26.76B45.93B34.68B51.69B
Operating Margin---0.18%32.83%39.72%30.09%32.95%
EBITDA---19.88B50.31B43.34B51.47B
EBITDA Margin---24.39%43.51%37.60%32.82%
Net Income-31.35M41.32M-36.06M13.40B38.83B29.11B35.22B
Net Income Margin---0.07%16.44%33.58%25.26%22.46%
R&D--888.13M570.83M967.61M1.72B1.89B
R&D as % of Total Revenue--1.74%0.70%0.84%1.49%1.20%
Interest Expense046.25M48.74M307.21M684.56M2.29B2.40B
Interest Expense % of Total Revenue--0.10%0.38%0.59%1.99%1.53%

Balance Sheet

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets11.32B11.40B11.40B73.79B153.27B177.90B217.25B
Total Liabilities698.47M737.52M777.88M16.73B53.99B51.11B59.87B
Total Equity10.62B10.66B10.62B57.06B99.28B126.80B157.38B
Cash1.31B265.93M202.78M1.51M12.18B32.85B32.50B
Total Debt644.99M691.24M-----
Net Debt-425.31M538.03M-4.54B--

Cash Flow

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-73.88M-48.57M6.09B14.78B25.96B14.93B51.14B
Investing Cash Flow-30.00B-1.00B-5.72B-6.75B-45.67B7.82B-
Financing Cash Flow34.02B--796.01M-4.06B25.67B-2.68B-
Capital Expenditure00510.16M543.19M3.17B1.96B1.32B
Free Cash Flow--48.57M-63.14M14.21B22.78B12.96B49.82B
Dividends Paid-----4.39B4.45B
FCF to OCF-100.00%-1.04%96.11%87.77%86.84%97.42%
Dividend Paid to FCF-----33.87%8.93%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Mar 16, 2022May 8, 2022Aug 10, 2022Nov 10, 2022Feb 9, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------103.0096.00113.50140.50101.50--------
EPS Actual-0.09-0.04-0.100.71-0.14-1.18-5.30139.8057.98-64.59102.8856.48134.25102.00101.00106.0067.0050.0053.86156.19133.38103.0087.6968.55116.78171.00
Surprise--------------0.97%5.21%-6.61%-52.31%-50.74%--------
Timing-------After-hoursAfter-hoursPre-marketAfter-hoursAfter-hours--------------

Key Statistics & Ratios

Market Cap442.04B
Enterprise Value341.66B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.64
Price / Book2.47
Revenue (TTM)167.35B
Gross Profit (TTM)112.02B
EBITDA45.43B
Profit Margin23.89%
Operating Margin23.35%
Return on Equity24.85%
Return on Assets11.00%
Shares Outstanding88.23M
Shares Float41.09M
Beta0.93
Dividend Yield1.00%
Dividend Rate50.00
Payout Ratio11.26%

Dividends

20252×
50.00Dec 29, 202550.00Mar 28, 2025
20231×
50.00Dec 27, 2023